![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
SHEN Shenandoah Telecommunications Co
- 11.900
- -0.010-0.08%
Close Feb 14 16:00 ET
- 11.900
- 0.0000.00%
Post 20:01 ET
649.77MMarket Cap3.22P/E (TTM)
12.140High11.750Low125.10KVolume11.970Open11.910Pre Close1.49MTurnover0.26%Turnover Ratio74.38P/E (Static)54.60MShares22.11752wk High0.70P/B572.93MFloat Cap10.42052wk Low0.09Dividend TTM48.15MShs Float38.045Historical High0.76%Div YieldTTM3.28%Amplitude0.624Historical Low11.917Avg Price1Lot Size
Shenandoah Telecommunications Co Stock Forum
Sign in to post a comment
Columns Cause and Effect
Oh, no, numbers did a thing!!!! PAN8C SELL
Anticipating rate cuts in September, businesses increased payrolls by re-hiring all the people they laid off earlier in the year or later to "protect margins."
Why wouldn't you try to get a head start on boosted demand for products?
Predictably, Old Money doesn't think past the week, so if nothing else, next week, will present entry points.
$ChromaDex (CDXC.US)$ Bioscience, aging products.
FY24 Estimates:
Sales growth +13% yoy
Gross marg...
Anticipating rate cuts in September, businesses increased payrolls by re-hiring all the people they laid off earlier in the year or later to "protect margins."
Why wouldn't you try to get a head start on boosted demand for products?
Predictably, Old Money doesn't think past the week, so if nothing else, next week, will present entry points.
$ChromaDex (CDXC.US)$ Bioscience, aging products.
FY24 Estimates:
Sales growth +13% yoy
Gross marg...
1
The low ROE and strategy of paying out most profits to shareholders may be causing disappointing earnings growth. Analysts predict further shrinkage in the company's earnings.
Shenandoah Telecommunications' high P/S ratio is justified by strong revenue growth and promising future prospects. Investors hold on to the stock, expecting a prosperous future.
Shenandoah Telecommunications' declining revenue and share price may shake investor confidence. Despite a slight bottom line improvement over the last three years, the company's future seems uncertain. Its recent share price performance raises some concerns as it compares unfavorably with its five-year TSR.
Shenandoah Telecommunications' falling ROCE and shrinking capital employed may signal future business problems. The company was unable to offer a positive growth path to its long-term investors, prompting analysts to recommend looking for other investment opportunities unless these metrics improve.
Upgrades
• $Fortinet (FTNT.US)$ : BMO Capital Upgrades to Outperform from Market Perform - PT $350 (from $325)
• $Microchip Technology (MCHP.US)$ : Stifel Upgrades to Buy from Hold - PT $75 (from $70)
• $Ovintiv (OVV.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $64 (from $56)
• $Riot Platforms (RIOT.US)$ : Compass Point Upgrades to Buy from Neutral - PT $14 (from $30)
• $Snowflake (SNOW.US)$ : Jefferies Upgrades to Buy f...
• $Fortinet (FTNT.US)$ : BMO Capital Upgrades to Outperform from Market Perform - PT $350 (from $325)
• $Microchip Technology (MCHP.US)$ : Stifel Upgrades to Buy from Hold - PT $75 (from $70)
• $Ovintiv (OVV.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $64 (from $56)
• $Riot Platforms (RIOT.US)$ : Compass Point Upgrades to Buy from Neutral - PT $14 (from $30)
• $Snowflake (SNOW.US)$ : Jefferies Upgrades to Buy f...
17
1
15
Gainers:
• $Belite Bio (BLTE.US)$ +17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)
• $Atkore (ATKR.US)$ +12.11% (earnings reports)
• $AST SpaceMobile (ASTS.US)$ +9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing)
• $Harmonic (HLIT.US)$ +7.56% (earnings reports)
• $The Chemours (CC.US)$ +7.2% ...
• $Belite Bio (BLTE.US)$ +17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)
• $Atkore (ATKR.US)$ +12.11% (earnings reports)
• $AST SpaceMobile (ASTS.US)$ +9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing)
• $Harmonic (HLIT.US)$ +7.56% (earnings reports)
• $The Chemours (CC.US)$ +7.2% ...
17
4
4
Upgrades
• $Agora (API.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $12.50
• $argenx SE (ARGX.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $375 (from $278)
• $Idacorp (IDA.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $110 (from $108)
• $Jakks Pacific (JAKK.US)$ : BMO Capital Upgrades to Outperform from Market Perform - PT $21
• $Coca-Cola FEMSA (KOF.US)$ : Barclays Upgrades to Overweight from Equal Wei...
• $Agora (API.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $12.50
• $argenx SE (ARGX.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $375 (from $278)
• $Idacorp (IDA.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $110 (from $108)
• $Jakks Pacific (JAKK.US)$ : BMO Capital Upgrades to Outperform from Market Perform - PT $21
• $Coca-Cola FEMSA (KOF.US)$ : Barclays Upgrades to Overweight from Equal Wei...
12
2
3
No comment yet
Trending Stocks
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!
Maggie0315 : Many people focus on the data itself and forget about politics.